Andrew J. Vickers, PhD; Margaret Pepe, PhD
Grant Support: In part by funds from David H. Koch provided through the Prostate Cancer Foundation, the Sidney Kimmel Center for Prostate and Urologic Cancers, and SPORE grant P50-CA92629 from the National Cancer Institute to Dr. Howard Scher. This work was also supported in part by a National Institutes of Health/National Cancer Institute Cancer Center Support Grant to Memorial Sloan-Kettering Cancer Center under award P30 CA00874 and by grant R01CA152089 from the National Institutes of Health.
Potential Conflicts of Interest: None disclosed. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M13-2841.
Requests for Single Reprints: Andrew J. Vickers, PhD, Department of Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street, 2nd Floor, New York, NY 10021; e-mail, email@example.com.
Current Author Addresses: Dr. Vickers: Department of Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street, 2nd Floor, New York, NY 10021.
Dr. Pepe: Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, PO Box 19024, Seattle, WA 98109-1024.
Vickers AJ, Pepe M. Does the Net Reclassification Improvement Help Us Evaluate Models and Markers?. Ann Intern Med. 2014;160:136–137. doi: https://doi.org/10.7326/M13-2841
Download citation file:
Published: Ann Intern Med. 2014;160(2):136-137.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use